High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: a dose-finding study.
Nagel
G A
GA
Department of Internal Medicine, University Hospital Göttingen.
Beyer
J H
JH
Holtkamp
W
W
Emrich
D
D
Kneba
M
M
Luig
H
H
Marschner
N
N
Rauschning
W
W
Unger
C
C
Wander
H E
HE
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D014751:Vindesine / Q000008:administration & dosage
D015251:Epirubicin; D003520:Cyclophosphamide; D014751:Vindesine; D005472:Fluorouracil